Stone House Investment Management, LLC Recursion Pharmaceuticals, Inc. Transaction History
Stone House Investment Management, LLC
- $380 Million
- Q2 2024
A detailed history of Stone House Investment Management, LLC transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Stone House Investment Management, LLC holds 1,000 shares of RXRX stock, worth $6,110. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,000
Previous 95
952.63%
Holding current value
$6,110
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding RXRX
# of Institutions
286Shares Held
236MCall Options Held
985KPut Options Held
2.4M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl28.1MShares$172 Million1.92% of portfolio
-
Baillie Gifford & CO26.6MShares$162 Million0.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA21.6MShares$132 Million0.0% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$106 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA15.4MShares$94 Million1.74% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $1.1B
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...